Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participants would be randomized to two groups: first, dilator insertion as usual, or second, mifepristone taken the day before the procedure.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boston University
• Collaborator: Society of Family Planning
• Treatments: Mifepristone

Criteria

Inclusion Criteria:

• women aged 18-45 having pregnancy termination at 14-16 weeks

Exclusion Criteria:

• multiple gestation, pre-existing infection, contraindication to osmotic dilators, unable to obtain proper consent